Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v6-EN
Language English English
Date Updated 2024-10-23 2024-10-23
Drug Identification Number 02265974 02265974
Brand name SEVOFLURANE SEVOFLURANE
Common or Proper name SEVOFLURANE SEVOFLURANE
Company Name BAXTER CORPORATION BAXTER CORPORATION
Ingredients SEVOFLURANE SEVOFLURANE
Strength(s) 99.97% 99.97%
Dosage form(s) LIQUID LIQUID
Route of administration INHALATION INHALATION INHALATION INHALATION
Packaging sizes (GTIN) (See additional packaging sizes) (See additional packaging sizes)
Additional packaging sizes 250 mL 250 mL
ATC code N01AB N01AB
ATC description ANESTHETICS, GENERAL ANESTHETICS, GENERAL
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2024-09-06 2024-09-06
Actual start date 2024-09-06 2024-09-06
Estimated end date 2024-10-22 2024-10-22
Actual end date 2024-10-22 2024-10-22
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments For questions or concerns contact Baxter customer care (1.888.719.9955) or your local Baxter representative. CA2L9117SV (Fused Bottle with integrated Safe-T-Seal Adaptor) is available as an alternative. For questions or concerns contact Baxter customer care (1.888.719.9955) or your local Baxter representative. CA2L9117SV (Fused Bottle with integrated Safe-T-Seal Adaptor) is available as an alternative.
Health Canada comments